Role of KATP channel in heat shock and pharmacological preconditioning

被引:11
作者
Kukreja, RC [1 ]
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Div Cardiol, Mol Cardiol Lab, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Med Coll Virginia, Div Cardiol, Lab Cellular Cardiol, Richmond, VA 23298 USA
来源
HEART IN STRESS | 1999年 / 874卷
关键词
D O I
10.1111/j.1749-6632.1999.tb09237.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Heat shock (HS) and 4-monophosphoryl Lipid A (MLA, a nontoxic analogue of endotoxin) protects the myocardium against ischemia-reperfusion injury. We studied the involvement of ATP-sensitive potassium channel (K-ATP channel) in ischemic protection induced by these stimuli. Anesthetized rabbits were preconditioned with either HS (by raising temperature to 42 degrees C for 15 min) or intravenous pretreatment with MLA (35 mu g/kg). After 24 h, animals were re-anesthetized and subjected to 30-min regional ischemia followed by 180-min reperfusion (I/R), K-ATP channel blockers glibenclamide and/or 5-hydroxydecanoate (5-HD) were used to inhibit channel function. The 72 kD heat shock protein (HSP-72) was measured by Western blots. HS produced a marked reduction in infarct size (39.4 =/- 8.1% to 14.3 +/- 2.5%, p < 0.05) that was abolished by glibenclamide (42.3 +/- 3.2%) and 5-HD (33.7 +/- 4.8%) when given before VR, These drugs faded to block HS protection when given before HS. Expression of HSP-72 was increased in all HS groups as compared to non-HS groups in both glibenclamide and 5-HD-treated rabbits. Similarly, pretreatment with MLA reduced infarct size from 40 +/- 8.68% to 15.1 +/- 1.5% (p < 0.05). The infarct size increased to 51.9 +/- 5.8 with 5-HD in MLA-treated rabbits. 5-HD did not alter infarct size significantly when given in vehicle-treated control rabbits. These data suggest that HS and MLA exert their antiischemic effect through activation of K-ATP channel.
引用
收藏
页码:211 / 221
页数:11
相关论文
共 46 条
[41]   LIMITATION OF INFARCT SIZE IN THE RABBIT BY ISCHEMIC PRECONDITIONING IS REVERSIBLE WITH GLIBENCLAMIDE [J].
TOOMBS, CF ;
MOORE, TL ;
SHEBUSKI, RJ .
CARDIOVASCULAR RESEARCH, 1993, 27 (04) :617-622
[42]  
Tosaki A, 1998, J PHARMACOL EXP THER, V285, P1274
[43]  
XIE QW, 1994, J BIOL CHEM, V269, P4705
[44]   EFFECTS OF MONOPHOSPHORYL LIPID-A ON MYOCARDIAL-ISCHEMIA REPERFUSION INJURY IN DOGS [J].
YAO, ZH ;
RASMUSSEN, JL ;
HIRT, JL ;
MEI, DA ;
PIEPER, GM ;
GROSS, GJ .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 (04) :653-663
[45]  
Yoshida K, 1996, MOL CELL BIOCHEM, V159, P73
[46]   Role of inducible nitric oxide synthase in pharmacological ''preconditioning'' with monophosphoryl lipid A [J].
Zhao, L ;
Weber, PA ;
Smith, JR ;
Comerford, ML ;
Elliott, GT .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (06) :1567-1576